Xiaoguang Huang | Pharmacology | Innovative Research Award

Published on 30/05/202630/05/2026 by Global Scholar Awards

Innovative Research Award

Xiaoguang Huang
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd, China

Xiaoguang Huang
Affiliation	Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
Country	China
Scopus ID	57221178957
Documents	3
Citations	2
h-index	1
Subject Area	Pharmacology
Event	Global Scholar Awards
Scopus	View Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and contributes to research activities within Pharmacology. His academic profile demonstrates participation in scientific publications, citation visibility, and pharmaceutical research engagement. These scholarly activities support recognition within the Global Scholar Awards and reflect continued involvement in pharmacological and healthcare-related scientific advancement.[1]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Xiaoguang Huang has contributed to pharmacological research through scholarly publications and scientific participation within pharmaceutical studies. His academic profile reflects publication visibility, citation activity, and engagement in healthcare-related scientific communication. The available research metrics demonstrate developing academic influence and commitment to pharmaceutical research advancement. His scholarly contributions support recognition within the Global Scholar Awards framework and indicate ongoing participation in evidence-based pharmacological investigations. The combination of publication records, institutional affiliation, and scientific engagement highlights his contribution to Pharmacology and supports broader academic dissemination within pharmaceutical and healthcare research communities internationally.[1]

Keywords

Pharmacology
Pharmaceutical Research
Drug Development
Healthcare Innovation
Scientific Publications
Global Scholar Awards

Introduction

Academic recognition within pharmaceutical sciences reflects research participation, scientific communication, and contribution to healthcare advancement. Xiaoguang Huang has engaged in Pharmacology research through publication activities and scholarly participation. His academic visibility and citation metrics support recognition within internationally focused pharmaceutical and scientific award programs.[1]

Research Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and maintains scholarly visibility through Scopus-indexed publications and citation-based research metrics. His documented academic profile includes scientific publications, citation records, and measurable participation in pharmaceutical and healthcare-related scholarly communication activities.[1]

Research Contributions

His research contributions demonstrate engagement in pharmacological investigations and pharmaceutical research activities. Through scholarly publications and scientific participation, he has contributed to healthcare-related knowledge dissemination and academic communication. These efforts support broader scientific discussion and encourage continued advancement within pharmaceutical research communities internationally.[2]

Publications

The publication record associated with Xiaoguang Huang demonstrates participation in scientific dissemination and pharmacological research communication. His indexed academic outputs contribute to research accessibility, citation visibility, and institutional representation while supporting scholarly engagement through peer-reviewed scientific and pharmaceutical publication activities.[1]

Research Impact

Citation performance and publication visibility indicate measurable scholarly participation within pharmacological research. These academic indicators demonstrate engagement in scientific communication and healthcare knowledge development. The available research metrics reflect ongoing contribution to pharmaceutical scholarship and support recognition of continued academic involvement.[1]

Award Suitability

Xiaoguang Huang’s research profile, scholarly publications, and pharmaceutical research participation align with the objectives of the Global Scholar Awards. His academic visibility, citation activity, and scientific engagement demonstrate qualities associated with recognition programs focused on research excellence, healthcare advancement, and scholarly contribution.[3]

Conclusion

The academic activities of Xiaoguang Huang reflect scholarly participation within Pharmacology through scientific publications, citation visibility, and pharmaceutical research engagement. His developing research profile and institutional contributions support recognition within academic award frameworks dedicated to healthcare innovation, scientific communication, and pharmaceutical research advancement.[1]

External Links

References

Elsevier. (n.d.). Scopus author details: Xiaoguang Huang, Author ID 57221178957. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57221178957
Global Scholar Awards. (n.d.). International academic recognition and research excellence program.
Global Scholar Awards
Huang, X., Zhang, A., Chen, D., Jia, Z., & Li, X. (2026). 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. SSRN Electronic Journal.
https://pubmed.ncbi.nlm.nih.gov/20347299/

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on 23/04/202523/04/2025 by Global Scholar Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
Year: 2021
Citations: 77
Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
Year: 2021
Citations: 51
Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
Authors: AP Rao, KJ Kaiser Jamil
Year: 2011
Citations: 32
Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
Authors: JV Rao, P Kavitha, AP Rao
Year: 2003
Citations: 24
Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
Authors: V Bakshi, PR Amarachinta, AK Chettupalli
Year: 2022
Citations: 23
Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
Year: 2023
Citations: 17
Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
Year: 2011
Citations: 15
Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
Year: 2014
Citations: 9
Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
Year: 2021
Citations: 8
Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
Year: 2012
Citations: 8
Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
Year: 2023
Citations: 6
Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
Authors: PR Amarachinta, KJ Kaiser Jamil
Year: 2012
Citations: 6
Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
Authors: MA Jahangir, AP Rao
Year: 2019
Citations: 4

Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Published on 25/09/202425/09/2024 by Global Scholar Awards

Dr. Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, Poland

Dr. Wirginia Krzyściak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. Krzyściak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses 🎓.

Professional profile

Education📚

Dr. Wirginia Krzyściak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 🎓. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. Krzyściak’s education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks 📚. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. Krzyściak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field 🔬.

Professional Experience🏛️

Dr. Wirginia Krzyściak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics 🧑‍🔬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. Krzyściak is an expert consultant for the Central Medical Laboratory in Bytom 🏥. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. Krzyściak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations 🎓. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.

Research Interest🌐

Dr. Wirginia Krzyściak’s research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience 🧠. She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances 🧪. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. Krzyściak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies 🔬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.

Awards and Honors🏆

Dr. Wirginia Krzyściak has received numerous prestigious awards and honors throughout her career 🌟. In 2024, she was awarded the Rector’s Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia 🏅. She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Dean’s Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. Krzyściak’s accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community 🧬.

Conclusion:

Dr. Wirginia Krzyściak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.

Publications top noted📜

From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
Krzyściak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
Scientific Reports (2024), 14(1), 5755
🔬 Citations: 1
Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
Krzyściak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
International Journal of Molecular Sciences (2024), 25(4), 2294
🧠 Citations: 0
Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
Magacz, M., Alatorre-Santamaría, S., Kędziora, K., Pamuła, E., Krzyściak, W.
International Journal of Molecular Sciences (2023), 24(15), 12136
🦷 Citations: 1
Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
Śmierciak, N., Krzyściak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
International Journal of Molecular Sciences (2023), 24(14), 11375
🧬 Citations: 3
The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
Krzyściak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
Biomedicines (2023), 11(2), 240
🧫 Citations: 4
Safety Assessment of the Modified Lactoperoxidase System—In Vitro Studies on Human Gingival Fibroblasts
Magacz, M., Papież, M., Kościelniak, D., Pamuła, E., Krzyściak, W.
International Journal of Molecular Sciences (2023), 24(3), 2640
🧪 Citations: 2
Risk Factors for Weight Gain in Patients with First-Episode Psychosis
Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
Psychiatria Polska (2023), 57(1), pp. 51–64
🏋️ Citations: 1
Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
Skalniak, A., Krzyściak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
Frontiers in Psychiatry (2023), 14, 1082135
💊 Citations: 4
Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Caries—An Open Label Randomized Controlled Trial
Staszczyk, M., Jamka-Kasprzyk, M., Kościelniak, D., Krzyściak, W., Jurczak, A.
International Journal of Environmental Research and Public Health (2022), 19(19), 12447
👶 Citations: 11

Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 06/09/202406/09/2024 by Global Scholar Awards

Dr. Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor at Chosun University, South Korea

Dr. Kyu Min Kim, born on July 13, 1984, is an Associate Professor at the Laboratory of Translational Genetics, Department of Biomedical Science, College of Natural Science, Chosun University, Korea. He also holds a position as a registered pharmacist in the Republic of Korea. 📅🏫

Professional profile

Scopus Profile.

Education📚

Dr. Kim completed his Ph.D. in Pharmacy with a focus on Molecular Pharmacology at Seoul National University (2011-2018), where he investigated antifibrotic targets in hepatic stellate cells. He obtained his M.S. in Pharmacy from Chosun University (2007-2009) and his B.S. in Pharmacy from the same institution (2003-2007). 🎓📚

Professional Experience🏛️

Dr. Kim has extensive experience in academia and research. He served as a Teaching and Research staff at Chosun University (Mar 2018 – Feb 2021) and as a researcher at several institutes, including the Research Institute of Pharmaceutical Science at Chosun University and Seoul National University. His career also includes experience as a pharmacist at Chonnam National University Hospital. 🏥🔬

Research Interest🌐

His research interests span molecular pharmacology, liver pathophysiology, and antifibrotic mechanisms. Dr. Kim focuses on hepatic stellate cell activation, liver fibrosis, and cellular responses to oxidative stress, aiming to understand and address complex biological and therapeutic challenges. 🔬💉

Awards and Honors🏆

Dr. Kim has received several accolades for his work, including the Excellent Paper Award at the 2nd China Chemical Looping Conference (2023), recognition as an Outstanding Graduate Student in Shanghai (2022), and the National Scholarship of the People’s Republic of China (2021). These honors underscore his significant contributions to his field. 🏆🎖️

Achievements🏅

Innovative Research Contributions:
- Developed novel insights into hepatic stellate cell activation and antifibrotic targets, enhancing understanding of liver fibrosis mechanisms. 🔬🧬
- Investigated the role of sphingosine kinase in liver pathophysiology, providing a deeper comprehension of liver-related diseases. 🌟🧪
Academic and Research Excellence:
- Awarded the Excellent Paper of the 2nd China Chemical Looping Conference (2023). 🏅🔬
- Recognized as an Outstanding Graduate Student in Shanghai (2022). 🏆🎓
- Received the National Scholarship of the People’s Republic of China (2021). 🎖️🌍
Professional Impact:
- Significant contributions to molecular pharmacology through various research roles at Chosun University and Seoul National University. 💼🏥
- Actively involved in advancing pharmacological research and education in his field. 📈👨‍🏫

Publications top noted📜

Parkin-Mediated Mitophagy by TGF-β Is Connected with Hepatic Stellate Cell Activation
- Authors: Lee, J.H., Kim, K.M.*, Jung, E.H., Cho, S.S., Ki, S.H.
- Journal: International Journal of Molecular Sciences
- Year: 2023
- Citations: 2 📄🔬
Integrative Roles of Sphingosine Kinase in Liver Pathophysiology
- Authors: Kim, K.M.*, Shin, E.J., Yang, J.H., Ki, S.H.
- Journal: Toxicological Research
- Year: 2023
- Citations: 4 🧬🔍
Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1
- Authors: Gao, Y., Sheng, X., Tan, D., Zhao, Y., Lee, S., Kim, K.M
- Journal: Advanced Science
- Year: 2023
- Citations: 2 📚✨
Protective Effect of Castanopsis sieboldii Extract against UVB-Induced Photodamage in Keratinocytes
- Authors: Lee, H.R., Yang, J.H., Lee, J.H., Kim, K.M., Shin, H.-J., Ki, S.H.
- Journal: Molecules
- Year: 2023
- Citations: 3 🌿🛡️
Ferroptosis Contributes to Hepatic Stellate Cell Activation and Liver Fibrogenesis
- Authors: Cho, S.S., Yang, J.H., Lee, J.H., Kim, K.M*, Ki, S.H.
- Journal: Free Radical Biology and Medicine
- Year: 2022
- Citations: 15 🩸⚠️
Regulated in Development and DNA Damage Response 1 Protects Hepatocytes Against Palmitate-Induced Lipotoxicity
- Authors: Kim, J.H., Kim, K.M*, Yang, J.H., Lee, J.H., Ki, S.H.
- Journal: Biotechnology and Bioprocess Engineering
- Year: 2022
- Citations: 0 🛡️🔬
Characterization of Hyperglycemia Due to Sub-Chronic Administration of Red Ginseng Extract via Comparative Global Proteomic Analysis
- Authors: Na, A.-Y., Jo, J.J., Kwon, O.K., Kim, J.H., Kim, K.M, Ki, S.H., Lee, S.
- Journal: Scientific Reports
- Year: 2021
- Citations: 3 🌱🔬
REDD1 Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis via Inhibiting the TGF-β/Smad Signaling Pathway
- Authors: Cho, S.S., Lee, J.H., Kim, K.M*, Yang, J.H., Ki, S.H.
- Journal: Free Radical Biology and Medicine
- Year: 2021
- Citations: 21 🌟💡
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
- Authors: Park, M., Kim, J.W., Kim, K.M*, Cho, Y., Lee, H., Baek, M.C., et al.
- Journal: Cancer Research
- Year: 2021
- Citations: 13 🦠🚀
Transforming Growth Factor Beta-Induced FoxO3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells
- Authors: Kim, S.J., Kim, K.M*, Yang, J.H., Park, E.Y., Ki, S.H.
- Journal: Toxicological Sciences
- Year: 2021
- Citations: 4 🔬🔄

Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 29/07/202429/07/2024 by Global Scholar Awards

Prof. Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor of Beijing Institute of Technology, China

Prof. Shaobo Ruan 🌟 is a distinguished academic with a focus on Pharmaceutics and Bioengineering. He earned his Ph.D. and M.D. in Pharmaceutics from the West China School of Pharmacy, Sichuan University 🎓, where he was mentored by Professors Huile Gao and Qin He. He also holds a B.S. in Pharmaceutics from Wannan Medical College. Prof. Ruan’s career includes significant roles as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science 🏛️, Beijing Institute of Technology, and as a Postdoctoral Associate at the University of Florida and the University of Kansas 🔬. His research and academic pursuits have made notable contributions to the field of Pharmaceutics and Bioengineering, emphasizing interdisciplinary approaches and advanced scientific inquiry.

Professional profile

Google Scholar.

Education📚

Prof. Shaobo Ruan 🎓 has an impressive educational background in Pharmaceutics. He completed his Ph.D. in Pharmaceutics at West China School of Pharmacy, Sichuan University (2015-2018) 🏫, under the guidance of Professors Huile Gao and Qin He. Prior to that, he earned his M.D. in Pharmaceutics from the same institution (2012-2015) 🏥. His foundational studies were completed with a B.S. in Pharmaceutics from Wannan Medical College (2008-2012) 🎓.

Professional Experience🏛️

Prof. Shaobo Ruan 🌟 has built a notable career in the field of Pharmaceutics and Bioengineering. He is currently serving as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️ since September 2021. Previously, he was a Postdoctoral Associate in Pharmaceutics at the University of Florida 🎓 from July 2020 to July 2021. He also held a Postdoctoral Associate position in Bioengineering at the University of Kansas 🔬 from July 2018 to June 2021. His roles have significantly contributed to advancements in his field, integrating research and interdisciplinary approaches.

Research Interest🌐

Prof. Shaobo Ruan 🔬 is deeply engaged in research that bridges Pharmaceutics and Bioengineering. His interests focus on the development and optimization of pharmaceutical formulations, drug delivery systems, and bioengineering applications 🌟. Prof. Ruan explores innovative methods to enhance drug efficacy and safety, integrating advanced technologies and interdisciplinary approaches to address complex challenges in the field. His work aims to advance therapeutic solutions and improve patient outcomes, making significant contributions to both scientific research and practical applications in Pharmaceutics and Bioengineering.

Awards and Honors🏆

Prof. Shaobo Ruan 🌟 has received notable recognition for his contributions to Pharmaceutics and Bioengineering. His excellence in research and academic achievements have earned him prestigious awards and honors 🏅. These accolades reflect his significant impact on the field, highlighting his dedication to advancing pharmaceutical sciences and bioengineering innovations. Prof. Ruan’s commitment to research and education continues to be acknowledged through various awards, underscoring his role as a leading figure in his discipline. 🏆✨

Achievements🏅

Ph.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🎓
M.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🏥
B.S. in Pharmaceutics from Wannan Medical College 🎓
Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️
Postdoctoral Associate at the University of Florida and University of Kansas 🔬
Advanced pharmaceutical formulations and drug delivery systems 🌟
Notable contributions to Bioengineering and interdisciplinary research ✨
Recognition through prestigious awards and honors 🏆

Projects🛠️

Development of Advanced Drug Delivery Systems 💉: Innovating methods to enhance the efficacy and safety of pharmaceutical formulations.
Optimization of Pharmaceutical Formulations 💊: Improving drug stability, release profiles, and therapeutic outcomes.
Bioengineering Applications in Pharmaceutics 🌟: Integrating bioengineering techniques to address complex pharmaceutical challenges.
Interdisciplinary Research Initiatives 🔍: Collaborating across fields to advance research in Pharmaceutics and Bioengineering.
Innovative Drug-Device Combination Products 💡: Designing and evaluating novel drug delivery systems that combine pharmaceuticals with medical devices.

Publications top noted📜

Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells
📄 Authors: M Zheng, S Ruan, S Liu, T Sun, D Qu, H Zhao, Z Xie, H Gao, X Jing, Z Sun
🏆 Journal: ACS Nano
📅 Year: 2015
🔍 Citations: 504
Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
📄 Authors: S Ruan, M Yuan, L Zhang, G Hu, J Chen, X Cun, Q Zhang, Y Yang, Q He, …
🏆 Journal: Biomaterials
📅 Year: 2015
🔍 Citations: 365
Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release
📄 Authors: S Ruan, X Cao, X Cun, G Hu, Y Zhou, Y Zhang, L Lu, Q He, H Gao
🏆 Journal: Biomaterials
📅 Year: 2015
🔍 Citations: 280
Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
📄 Authors: R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, …
🏆 Journal: Chinese Chemical Letters
📅 Year: 2023
🔍 Citations: 271
Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
📄 Authors: C Hu, X Cun, S Ruan, R Liu, W Xiao, X Yang, Y Yang, C Yang, H Gao
🏆 Journal: Biomaterials
📅 Year: 2018
🔍 Citations: 248
Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
📄 Authors: S Ruan, C Hu, X Tang, X Cun, W Xiao, K Shi, Q He, H Gao
🏆 Journal: ACS Nano
📅 Year: 2016
🔍 Citations: 243
Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma
📄 Authors: S Ruan, Q He, H Gao
🏆 Journal: Nanoscale
📅 Year: 2015
🔍 Citations: 174
Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
📄 Authors: S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, …
🏆 Journal: Nano Letters
📅 Year: 2019
🔍 Citations: 151
A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration
📄 Authors: X Cun, J Chen, S Ruan, L Zhang, J Wan, Q He, H Gao
🏆 Journal: ACS Applied Materials & Interfaces
📅 Year: 2015
🔍 Citations: 136
Acid‐responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery
📄 Authors: S Ruan, L Qin, W Xiao, C Hu, Y Zhou, R Wang, X Sun, W Yu, Q He, H Gao
🏆 Journal: Advanced Functional Materials
📅 Year: 2018
🔍 Citations: 131
Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization
📄 Authors: S Ruan, Y Zhou, X Jiang, H Gao
🏆 Journal: Advanced Science
📅 Year: 2021
🔍 Citations: 120
A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan
📄 Authors: X Cun, S Ruan, J Chen, L Zhang, J Li, Q He, H Gao
🏆 Journal: Acta Biomaterialia
📅 Year: 2016
🔍 Citations: 118
A simple one-step method to prepare fluorescent carbon dots and their potential application in non-invasive glioma imaging
📄 Authors: S Ruan, J Qian, S Shen, J Zhu, X Jiang, Q He, H Gao
🏆 Journal: Nanoscale
📅 Year: 2014
🔍 Citations: 116